Safety of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan

被引:0
|
作者
Hiroki Nagai
Shiro Tanaka
Miyuki Niimi
Nanae Seo
Takahiko Sasaki
Hiroshi Date
Michiaki Mishima
Hiroyasu Yasuda
Kazuhiro Yanagihara
机构
[1] Outpatient Oncology Unit,Department of Respiratory Medicine, Graduate School of Medicine
[2] Kyoto University Hospital,Department of Clinical Trial Design and Management, Translational Research Center
[3] Kyoto University,Department of Respiratory Medicine
[4] Kyoto University Hospital,Department of Thoracic Surgery, Graduate School of Medicine
[5] Tohoku University School of Medicine,Department of Clinical Application
[6] Kyoto University,Department of Translational Clinical Oncology, Graduate School of Medicine
[7] Tohoku University Translational Research Center,undefined
[8] Kyoto University,undefined
关键词
Erlotinib; Epidermal growth factor receptor; Epidermal growth factor receptor–tyrosine kinase inhibitor; Adverse events; Non-small-cell lung cancer; Japanese outpatients;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer
    Zhou, Songwen
    Ren, Shengxiang
    Yan, Lianghua
    Zhang, Ling
    Tang, Liang
    Zhang, Jie
    Zhou, Caicun
    RESPIROLOGY, 2009, 14 (05) : 709 - 715
  • [42] Efficacy and Safety of Nivolumab in Previously Treated Patients With Non-Small-cell Lung Cancer: Real World Experience in Argentina
    Martin, Claudio
    Lupinacci, Lorena
    Perazzo, Florencia
    Bas, Carlos
    Carranza, Omar
    Puparelli, Carmen
    Kowalyszyn, Ruben
    Magri, Ignacio
    Varela, Mirta
    Richardet, Eduardo
    Vera, Karina
    Foglia, Silvia
    Jerez, Ignacio
    Aman, Enrique
    Martinengo, Gaston
    Batagelj, Emilio
    Dri, Alejandro
    Pilnik, Norma
    Roa, Guillermo M.
    Mando, Pablo
    Tsou, Florencia
    Recondo, Gonzalo
    Cayol, Federico
    Flores, Marcos
    Sena, Susana
    Bagnes, Claudia
    Waisberg, Federico D.
    Minatta, Jose N.
    Rizzo, Manglio
    CLINICAL LUNG CANCER, 2020, 21 (05) : E380 - E387
  • [43] Safety and efficacy of nivolumab plus recombinant human endostatin in previously treated advanced non-small-cell lung cancer
    Lv, Weize
    Pei, Xiaofeng
    Zhao, Wenhua
    Cong, Yunyan
    Wei, Yajun
    Li, Ting
    Zhang, Hongyu
    Lin, Zhong
    Saito, Yuichi
    Kim, Jae Jun
    Liang, Zibin
    Zhong, Beilong
    Wang, Zhihui
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (02) : 201 - 212
  • [44] Second-line erlotinib for non-small-cell lung cancer
    Lorusso, Vito
    Cinieri, Saverio
    LANCET ONCOLOGY, 2012, 13 (04): : E141 - E142
  • [45] Clinical and economic review of erlotinib in non-small-cell lung cancer
    Yeung, Kai
    Carlson, Josh J.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (04) : 411 - 423
  • [46] Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer
    Hanna, Nasser
    Lilenbaum, Rogerio
    Ansari, Rafat
    Lynch, Thomas
    Govindan, Ramaswamy
    Jaenne, Pasi A.
    Bonomi, Philip
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5253 - 5258
  • [47] Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer
    Nishiyama, Akihiro
    Katakami, Nobuyuki
    Yoshioka, Hiroshige
    Iwasaku, Masahiro
    Korogi, Yohei
    Hata, Akito
    Takeshita, Jumpei
    Otsuka, Kojiro
    Nishino, Kazumi
    Uchida, Junji
    Okuyama, Takako
    Namba, Yoshinobu
    Mori, Masahide
    Fujita, Shiro
    Morita, Satoshi
    LUNG CANCER, 2015, 89 (03) : 301 - 305
  • [48] A retrospective analysis of cisplatin, pemetrexed, and bevacizumab in previously treated non-small-cell lung cancer
    Liu, Ke-Jun
    Wu, Hai-Ying
    ONCOTARGET, 2015, 6 (26) : 22750 - 22757
  • [49] Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Gerber, David E.
    Spigel, David R.
    Giorgadze, David
    Shtivelband, Mikhail
    Ponomarova, Olga V.
    Shan, Joseph S.
    Menander, Kerstin B.
    Belani, Chandra P.
    CLINICAL LUNG CANCER, 2016, 17 (03) : 169 - 176
  • [50] Surgical outcomes of non-small-cell lung carcinoma in patients previously treated for gastric cancer
    Tsubokawa, Norifumi
    Mimae, Takahiro
    Aokage, Keiju
    Hattori, Aritoshi
    Suzuki, Kenji
    Nagai, Kanji
    Tsuboi, Masahiro
    Okada, Morihito
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2015, 47 (04) : 648 - 652